SKY Packaging is voluntarily recalling HydrALAZINE Hydrochloride (25 mg and 50 mg) unit dose tablets, which are used to treat high blood pressure. The recall was initiated because the tablets failed to meet quality specifications for impurities and degradation during testing. Consumers who have these tablets should contact their healthcare provider or pharmacist and should not continue use without a suitable replacement.
Taking medication that has degraded or contains impurities may lead to the treatment being less effective at controlling blood pressure or potentially expose patients to harmful chemical byproducts. To date, no specific injuries or adverse events have been reported regarding these affected lots.
You have 2 options:
Manufactured by Strides Pharma Science Ltd, Bengaluru, India
Manufactured by Strides Pharma Science Ltd, Bengaluru, India
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.